Application of metagenomic next-generation sequencing in diagnosis and treatment of severe infection of hematological disorder_West China Medical Journal

Authors：

DENG Jiaowen ¹ , LI Yongli ¹ , LIU Qian ¹ , LI Zhiyuan ¹ , BIAN Tierong ² , HE Guangfeng ¹ , YUAN Kaifeng ¹ , LIN Fanli ¹ ,  XING Hongyun ¹

1. Department of Hematology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P. R. China;
2. Medical Experimental Center, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P. R. China;

Corresponding?author：

XING Hongyun, Email: xinghy52003@foxmail.com

Keywords：

Hematological disorder; infection; metagenomic next-generation sequencing; traditional method; clinical application

DOI：

10.7507/1002-0179.202205091

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To explore the clinical value of metagenomic next-generation sequencing (mNGS) in the diagnosis and treatment of severe and complex infection of malignant hematological disorder. Methods The mNGS test results, traditional etiology test results and general clinical data of inpatients with malignant hematological disorder in the Department of Hematology, the Affiliated Hospital of Southwest Medical University between June 2020 and February 2022 were retrospectively analyzed. To explore the clinical application value of mNGS in the diagnosis and treatment of severe complicated infection of hematological disorder. Results A total of 21 patients were included. The samples included 18 peripheral blood samples, 2 pleural fluid samples and 1 alveolar lavage fluid sample. In the included patients, through mNGS, pathogenic bacteria were directly detected in 17 patients, including 8 fungi, 9 bacteria and 10 viruses, of which 9 were mixed infections. The positive rate (81.0% vs. 33.3%, P=0.002), sensitivity (85.7% vs. 30.0%), granulocytopenia (9 vs. 3 cases, P=0.031) and the types of pathogen (Z=?3.416, P=0.001) detected by mNGS were all higher than those by traditional method. The infection control of 17 patients improved in varying degrees after adjusting the treatment plan according to the test results. Conclusions mNGS has significantly higher detection rate and sensitivity for bacteria, fungi, viruses and mixed infections. Compared with the traditional method, mNGS has more efficient characteristics. Its clinical application can further improve the diagnosis and treatment efficiency of severe complicated infection of malignant hematological disorder, and thus improve the survival rate of patients.

Citation： DENG Jiaowen, LI Yongli, LIU Qian, LI Zhiyuan, BIAN Tierong, HE Guangfeng, YUAN Kaifeng, LIN Fanli, XING Hongyun. Application of metagenomic next-generation sequencing in diagnosis and treatment of severe infection of hematological disorder. West China Medical Journal, 2022, 37(8): 1161-1165. doi: 10.7507/1002-0179.202205091 Copy

1.	宋曉超, 楊海飛, 陳凱, 等. 2013—2018 年惡性血液病患者血流感染病原菌與耐藥性變遷. 中華醫院感染學雜志, 2018, 28(11): 1641-1644, 1692.
2.	Miao Q, Ma Y, Wang Q, et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical Practice. Clin Infect Dis, 2018, 67(Suppl-2): S231-S240.
3.	Lefterova MI, Suarez CJ, Banaei N, et al. Next-generation sequencing for infectious disease diagnosis and management: a report of the association for molecular pathology. J Mol Diagn, 2015, 17(6): 623-634.
4.	Escrihuela-Vidal F, Laporte J, Albasanz-Puig A,et al. Update on the management of febrile neutropenia in hematologic patients. Rev Esp Quimioter, 2019, 32(Suppl 2): 55-58.
5.	閆晨華, 徐婷, 鄭曉云, 等. 中國血液病患者中性粒細胞缺乏伴發熱的多中心、前瞻性流行病學研究. 中華血液學雜志, 2016, 37(3): 177-182.
6.	胡付品, 郭燕, 朱德妹, 等. 2018 年 CHINET 中國細菌耐藥性監測. 中國感染與化療雜志, 2020, 20(1): 1-10.
7.	Metan G, Demiraslan H, Kaynar LG, et al. Factors influencing the early mortality in haematological malignancy patients with nosocomial gram negative bacilli bacteraemia: a retrospective analysis of 154 cases. Braz J Infect Dis, 2013, 17(2): 143-149.
8.	Averbuch D, Orasch C, Cordonnier C, et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on infections in leukemia. Haematologica, 2014, 99(2): 400.
9.	Fenollar F, Raoult D. Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int J Antimicrob Agents, 2007, 30(Suppl 1): S7-S15.
10.	劉進. 侵襲性真菌病診治進展. 現代實用醫學, 2010, 22(5): 481-484.
11.	蔡素芳, 胡建達. 血液病患者繼發侵襲性真菌病診治的現狀及進展. 臨床血液學雜志, 2009, 22(7): 400-402.
12.	Ruhnke M, Böhme A, Buchheidt D, et al. Diagnosis of invasive fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGHIO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol, 2003, 82(Suppl 2): S141-148.
13.	Duan H, Li X, Mei A, et al. The diagnostic value of metagenomic next-generation sequencing in infectious diseases. BMC Infect Dis, 2021, 21(1): 62.
14.	Long Y, Zhang Y, Gong Y, et al. Diagnosis of sepsis with cell-free DNA by next-generation sequencing technology in ICU patients. Arch Med Res, 2016, 47(5): 365-371.
15.	Lee RA, Al Dhaheri F, Pollock NR, et al. Assessment of the clinical utility of plasma metagenomic next-generation sequencing in a pediatric hospital population. J Clin Microbiol, 2020, 58(7): e00419-20.
16.	Simner PJ, Miller S, Carroll KC, et al. Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases. Clin Infect Dis, 2018, 66(5): 778-788.
17.	Luan Y, Hu H, Liu C, et al. A proof-of-concept study of an automated solution for clinical metagenomic next-generation sequencing. J Appl Microbiol, 2021, 131(2): 1007-1016.
18.	鄧少麗, 陳鳴. 關注基因檢測在臨床實踐中的倫理學問題. 中華檢驗醫學雜志, 2016, 39(7): 481-483.
19.	中華醫學會檢驗醫學分會. 高通量宏基因組測序技術檢測病原微生物的臨床應用規范化專家共識. 中華檢驗醫學雜志, 2020, 43(12): 1181-1195.

1. 宋曉超, 楊海飛, 陳凱, 等. 2013—2018 年惡性血液病患者血流感染病原菌與耐藥性變遷. 中華醫院感染學雜志, 2018, 28(11): 1641-1644, 1692.
2. Miao Q, Ma Y, Wang Q, et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical Practice. Clin Infect Dis, 2018, 67(Suppl-2): S231-S240.
3. Lefterova MI, Suarez CJ, Banaei N, et al. Next-generation sequencing for infectious disease diagnosis and management: a report of the association for molecular pathology. J Mol Diagn, 2015, 17(6): 623-634.
4. Escrihuela-Vidal F, Laporte J, Albasanz-Puig A,et al. Update on the management of febrile neutropenia in hematologic patients. Rev Esp Quimioter, 2019, 32(Suppl 2): 55-58.
5. 閆晨華, 徐婷, 鄭曉云, 等. 中國血液病患者中性粒細胞缺乏伴發熱的多中心、前瞻性流行病學研究. 中華血液學雜志, 2016, 37(3): 177-182.
6. 胡付品, 郭燕, 朱德妹, 等. 2018 年 CHINET 中國細菌耐藥性監測. 中國感染與化療雜志, 2020, 20(1): 1-10.
7. Metan G, Demiraslan H, Kaynar LG, et al. Factors influencing the early mortality in haematological malignancy patients with nosocomial gram negative bacilli bacteraemia: a retrospective analysis of 154 cases. Braz J Infect Dis, 2013, 17(2): 143-149.
8. Averbuch D, Orasch C, Cordonnier C, et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on infections in leukemia. Haematologica, 2014, 99(2): 400.
9. Fenollar F, Raoult D. Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int J Antimicrob Agents, 2007, 30(Suppl 1): S7-S15.
10. 劉進. 侵襲性真菌病診治進展. 現代實用醫學, 2010, 22(5): 481-484.
11. 蔡素芳, 胡建達. 血液病患者繼發侵襲性真菌病診治的現狀及進展. 臨床血液學雜志, 2009, 22(7): 400-402.
12. Ruhnke M, Böhme A, Buchheidt D, et al. Diagnosis of invasive fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGHIO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol, 2003, 82(Suppl 2): S141-148.
13. Duan H, Li X, Mei A, et al. The diagnostic value of metagenomic next-generation sequencing in infectious diseases. BMC Infect Dis, 2021, 21(1): 62.
14. Long Y, Zhang Y, Gong Y, et al. Diagnosis of sepsis with cell-free DNA by next-generation sequencing technology in ICU patients. Arch Med Res, 2016, 47(5): 365-371.
15. Lee RA, Al Dhaheri F, Pollock NR, et al. Assessment of the clinical utility of plasma metagenomic next-generation sequencing in a pediatric hospital population. J Clin Microbiol, 2020, 58(7): e00419-20.
16. Simner PJ, Miller S, Carroll KC, et al. Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases. Clin Infect Dis, 2018, 66(5): 778-788.
17. Luan Y, Hu H, Liu C, et al. A proof-of-concept study of an automated solution for clinical metagenomic next-generation sequencing. J Appl Microbiol, 2021, 131(2): 1007-1016.
18. 鄧少麗, 陳鳴. 關注基因檢測在臨床實踐中的倫理學問題. 中華檢驗醫學雜志, 2016, 39(7): 481-483.
19. 中華醫學會檢驗醫學分會. 高通量宏基因組測序技術檢測病原微生物的臨床應用規范化專家共識. 中華檢驗醫學雜志, 2020, 43(12): 1181-1195.

West China Medical Journal

Application of metagenomic next-generation sequencing in diagnosis and treatment of severe infection of hematological disorder

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content